|
(V579) |
Quantification of amyloid load in endomyocardial biopsies: The potential role for risk stratification |
|
|
E. Brokbals, A. V. Kristen, F. aus dem Siepen, H. A. Katus, C. Röcken (Heidelberg, Kiel) |
|
|
Diskussion |
|
(V580) |
Cardiac involvement in Duchenne/Becker muscular dystrophy carriers in comparison to their first degree male relatives – a comparative cardiovascular magnetic resonance study |
|
|
A. R. Florian, A. Ludwig, S. Rösch, U. Sechtem, A. Yilmaz (Münster, Stuttgart) |
|
|
Diskussion |
|
(V581) |
In Vivo Characterization of Dilated Cardiomyopathy (DCM)-modifier Genes in Zebrafish |
|
|
S. Westphal, M. Rattka, S. Just, W. Rottbauer (Ulm) |
|
|
Diskussion |
|
(V582) |
Myosin mutations in Familial Hypertrophic Cardiomyopathy: Unequal fraction of mutated myosin in individual cardiomyocytes as possible trigger for disease development. |
|
|
M. Makul, J. Montag, S. Tripathi, S. Dunda, A. Perrot, A. Francino, F. Navarro-Lopez, B. Brenner, T. Kraft (Hannover, Berlin; Barcelona, ES) |
|
|
Diskussion |
|
(V583) |
Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay in cardiac myocytes of a HCM mouse model |
|
|
M. Nasib, F. W. Friedrich, F. Flenner, T. Eschenhagen, L. Carrier (Hamburg) |
|
|
Diskussion |
|
(V584) |
Predictors of Long-term Outcome after Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy |
|
|
L. Faber, A. Burghardt, H. Seggewiß, O. Oldenburg, D. Horstkotte (Bad Oeynhausen, Schweinfurt) |
|
|
Diskussion |